SCHEMBL26008334

SCHEMBL26008334

CC(=O)[C@H](N)CNC(=O)C1CCN(CC(=O)O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38
GNAI3 P08754 1/20 0.38
GNAO1 P09471 1/20 0.38
GNAI1 P63096 1/20 0.38
GSK3B P49841 1/20 0.38
DYRK1A Q13627 1/20 0.38
KDM4E B2RXH2 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GAA P10253 2/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25354278 0.89 ITGB3 (0.47) ALDH1A1ITGB3ITGA2BGNAI3GNAO1
SCHEMBL26009590 0.89 ITGB3 (0.47) ALDH1A1ITGB3ITGA2BGNAI3GNAO1
SCHEMBL25354268 0.89 ITGB3 (0.47) ALDH1A1ITGB3ITGA2BGNAI3GNAO1
SCHEMBL26008158 0.83 ITGB3 (0.46) ALDH1A1ITGB3ITGA2BGNAI3GNAO1
SCHEMBL26008332 0.82 ALDH1A1 (0.38) ALDH1A1GNAI3GNAO1GNAI1GSK3B
SCHEMBL25357386 0.78 FOLH1 (0.41) ALDH1A1ITGB3ITGA2BGNAI3GNAO1
SCHEMBL25357374 0.78 FOLH1 (0.41) ALDH1A1ITGB3ITGA2BGNAI3GNAO1
SCHEMBL26009827 0.76 FOLH1 (0.51) ALDH1A1ITGB3ITGA2BGNAI3GNAO1
SCHEMBL25356825 0.76 FOLH1 (0.51) ALDH1A1ITGB3ITGA2BGNAI3GNAO1
SCHEMBL26009225 0.75 HSD17B10 (0.41) ITGB3ITGA2BGSK3BSMN1; SMN2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP ALDH1A1 4385/4885ITGB3 4109/4885ITGA2B 3548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.